Skip to main content
. 2016 Jul 12;7(45):72381–72394. doi: 10.18632/oncotarget.10546

Table 1. Characteristics of study participants (N = 32,584).

Variable Cases (n= 10,891) Controls (n= 21,693)
Age at diagnosis/interview(y), mean (SD) 58.1 (11.4) 56.1 (24.9)
History of pregnancy
 Yes 6021 (80.4) 15190 (87.9)
 No 1318 (17.6) 1868 (10.8)
 Unknown 149 (2.0) 217 (1.3)
Oral contraceptive use
 Ever 4017 (57.4) 10572 (63.3)
 Never 2864 (41.0) 5900 (35.3)
 Unknown 112 (1.6) 243 (1.5)
Histology
 Serous 6500 (59.7) NA
 Mucinous 696 (6.4)
 Endometrioid 1439 (13.2)
 Clear Cell 660 (6.1)
 Mixed Cell 369 (3.4)
 Other or unknown epithelial type 1227(11.3)
Stage
 Localized 1425 (15.7) NA
 Regional 1838 (20.2)
 Distant 5721 (63.0)
 Unknown 103 (1.1)
Grade
 I/II 2882 (32.8) NA
 III/IV 5174 (58.9)
 Other/Unknown 729 (8.3)